3rd Quarter - Report

BLUEBIRD STRATEGIES for ATA ACTION

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Access to Prescription Digital Therapeutics Act of 2025 (H.R.3288/S. 1702)

LobbyistCovered position, as disclosed
JOHN KEVIN BRENNAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1702 (119th), H.R. 3288 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.